Literature DB >> 16039053

Functional role of prostacyclin receptor in rat dorsal root ganglion neurons.

Koichi Nakae1, Fumihiko Hayashi, Mayumi Hayashi, Noriyuki Yamamoto, Takashi Iino, Satoru Yoshikawa, Jang Gupta.   

Abstract

Recent studies on prostanoids showed that some of prostanoid receptors are expressed in rat dorsal root ganglion (DRG) neurons. These facts suggest that prostanoid receptors might be involved in the excitation mechanism of DRG neurons. In the present study, PCR experiments revealed that one of prostanoid receptor, prostacyclin receptor (IP receptor) was expressed in L6 and S1 rat DRG neurons and that the expression of IP receptor was not changed in DRG neurons obtained from the cyclophosphamide (CYP)-induced cystitis rat. We examined the functional role of IP receptor agonist and other prostanoids by measuring cyclic AMP (cAMP) accumulation and substance P (SP) release in primary cultured DRG neurons. The pretreatment of DRG neurons with prostanoid agonists such as iloprost (IP), butaprost (EP(2)), misoprostol (EP(2-4)), PGE(2) (EP(1-4)) or PGD(2) (DP and CRTH2) sensitized the DRG neurons and hence potentiated the lys-bradykinin-induced SP release. The increase of SP release by lys-BK plus prostanoid agonists was proportion to cAMP accumulation. Iloprost was the most potent agonist to induce cAMP accumulation and SP release among prostanoid agonists evaluated in this study and its effect is mediated by IP receptor. Moreover, capsaicin-, ATP- and KCl-induced SP release was also enhanced by iloprost although iloprost did not change intracellular Ca(2+) and membrane depolarization induced by these chemical stimuli. These results strongly indicate that IP receptor play an important role in the sensitization of rat sensory neuron.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039053     DOI: 10.1016/j.neulet.2005.06.058

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

Review 1.  Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology.

Authors:  Hayamitsu Adachi; Koichi Nakae; Shuichi Sakamoto; Chisato Nosaka; Sonoko Atsumi; Masabumi Shibuya; Nobuaki Higashi; Motowo Nakajima; Tatsuro Irimura; Yoshio Nishimura
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

2.  RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists.

Authors:  Keith R Bley; Anindya Bhattacharya; Don V Daniels; Joel Gever; Alam Jahangir; Counde O'Yang; Steven Smith; Dinesh Srinivasan; Anthony P D W Ford; Mary-Frances Jett
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Alpha2-adrenoreceptor mediated sympathoinhibition of heart rate during acute hypoxia is diminished in conscious prostacyclin synthase deficient mice.

Authors:  James T Pearson; Mikiyasu Shirai; Chieko Yokoyama; Hirotsugu Tsuchimochi; Daryl O Schwenke; Akito Shimouchi; Kenji Kangawa; Tadashi Tanabe
Journal:  Pflugers Arch       Date:  2006-11-22       Impact factor: 3.657

4.  Transcriptional Profiling of Cutaneous MRGPRD Free Nerve Endings and C-LTMRs.

Authors:  Ana Reynders; Annabelle Mantilleri; Pascale Malapert; Stéphanie Rialle; Sabine Nidelet; Sophie Laffray; Corinne Beurrier; Emmanuel Bourinet; Aziz Moqrich
Journal:  Cell Rep       Date:  2015-02-13       Impact factor: 9.423

Review 5.  Molecular mechanisms underlying the actions of arachidonic acid-derived prostaglandins on peripheral nociception.

Authors:  Yongwoo Jang; Minseok Kim; Sun Wook Hwang
Journal:  J Neuroinflammation       Date:  2020-01-22       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.